Skip to main content
Montanide-Adjuvant-Porc-Innocuité

Swine

MONTANIDE™, high efficacy / safety balance for swine vaccine

Vaccination programs in swine industry are a major contribution to its productivity thanks to an increase of herd health.
The role of the adjuvant is essential for vaccine efficacy, antigens being more and more purified. The choice of the adjuvant in the vaccine must consider several criteria: the disease, the type of antigen (live or inactivated), the immune response kinetics (short/long term protection), the type of immune response (humoral and/or cellular) and the administration route (injection or mucosal). Adjuvant safety is also a key factor when developing vaccines for sensitive animals such as pigs. SEPPIC provides a dedicated range of MONTANIDE™ which meets expectations for swine vaccine development.

MONTANIDE™ for swine vaccines

Five adjuvant technologies are usually recommended for swine vaccines:

  • Water-in-Oil emulsions: MONTANIDE™ ISA
  • Water-in-Oil-in-Water emulsions: MONTANIDE™ ISA
  • Oil-in-Water emulsions: MONTANIDE™ ISA
  • Micro-emulsions: MONTANIDE™ IMS
  • Polymers: MONTANIDE™ GEL
MONTANIDE™ offer for swine vaccines

MONTANIDE™ in the field

MONTANIDE™ adjuvants are used worldwide in vaccines for pigs, sows and piglets against viral, bacterial or parasitic diseases, such as:

  • Foot and Mouth Disease (FMD)
  • Aujeszky’s disease
  • Porcine parvovirus
  • Porcine reproductive and respiratory syndrome (PRRS)
  • Actinobacillus pleuropneumoniae (APP)
  • Pasteurella multocida
  • Mycoplasma Hyopneumoniae
  • Bordetella Bronchiseptica
  • Streptococcus suis